Balance Sheet British American Tobacco p.l.c.

Equities

BATS

GB0002875804

Tobacco

Market Closed - London S.E. Other stock markets 11:35:22 2025-07-18 EDT			5-day change	1st Jan Change
3,812.00 ^GBX	-0.03%		+0.63%	+32.36%

07-17	Juul Labs Wins FDA Clearance to Keep E-Cigarettes on US Market	MT
07-17	FDA approves Juul's tobacco and menthol e-cigarettes	RE

a4d31230cd23e810d2a62a5acda.OluCEKt_6MPPhNoMdCjLa1DP7ZpcDfzh69gii6sPm6w.XCzgfuItsvaJw7ZgMG2JBDiQuekIPb3XgI8awZNp1s0MPMpV9AmZpvnnvQ

Published financial data: BRITISH AMERICAN TOBACCO P.L.C.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	25.78B	25.68B	27.66B	27.28B	25.87B
Total Revenues	25.78B	25.68B	27.66B	27.28B	25.87B
Cost of Goods Sold, Total	4.14B	4.6B	4.8B	4.89B	4.57B
Gross Profit	21.64B	21.09B	22.85B	22.39B	21.3B
Selling General & Admin Expenses, Total	2.65B	3.81B	3.83B	3.86B	3.95B
Depreciation & Amortization - (IS)	1.09B	938M	962M	849M	2.23B
Other Operating Expenses	6.83B	5.34B	6.41B	5.05B	5.32B
Other Operating Expenses, Total	10.57B	10.09B	11.2B	9.75B	11.5B
Operating Income	11.07B	11B	11.65B	12.64B	9.8B
Interest Expense, Total	-1.81B	-1.5B	-1.66B	-1.83B	-1.77B
Interest And Investment Income	50M	35M	92M	186M	251M
Net Interest Expenses	-1.76B	-1.47B	-1.57B	-1.64B	-1.52B
Income (Loss) On Equity Invest.	455M	415M	442M	585M	1.9B
Currency Exchange Gains (Loss)	-225M	171M	-491M	432M	-2M
Other Non Operating Income (Expenses)	234M	-166M	324M	-620M	-111M
EBT, Excl. Unusual Items	9.77B	9.95B	10.36B	11.39B	10.06B
Restructuring Charges	-408M	-150M	-774M	2M	-
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-209M	-57M	-	-4.61B	-39M
Gain (Loss) On Sale Of Investments	-	-24M	-	-	-6M
Gain (Loss) On Sale Of Assets	-	-358M	6M	-546M	62M
Asset Writedown	-	-92M	-123M	-23.11B	-828M
Legal Settlements	-508M	-81M	-144M	-156M	-6.3B
Other Unusual Items	25M	-26M	-	-29M	590M
EBT, Incl. Unusual Items	8.67B	9.16B	9.32B	-17.06B	3.54B
Income Tax Expense	2.11B	2.19B	2.48B	-2.87B	357M
Earnings From Continuing Operations	6.56B	6.97B	6.85B	-14.19B	3.18B
Net Income to Company	6.56B	6.97B	6.85B	-14.19B	3.18B
Minority Interest	-164M	-173M	-180M	-178M	-113M
Net Income - (IS)	6.4B	6.8B	6.67B	-14.37B	3.07B
Preferred Dividend and Other Adjustments	-	12M	49M	45M	42M
Net Income to Common Incl Extra Items	6.4B	6.79B	6.62B	-14.41B	3.03B
Net Income to Common Excl. Extra Items	6.4B	6.79B	6.62B	-14.41B	3.03B
Per Share Items
Net EPS - Basic	2.8	2.97	2.93	-6.47	1.37
Basic EPS - Continuing Operations	2.8	2.97	2.93	-6.47	1.37
Basic Weighted Average Shares Outstanding	2.29B	2.29B	2.26B	2.23B	2.21B
Net EPS - Diluted	2.79	2.96	2.92	-6.47	1.36
Diluted EPS - Continuing Operations	2.79	2.96	2.92	-6.47	1.36
Diluted Weighted Average Shares Outstanding	2.3B	2.3B	2.27B	2.23B	2.22B
Normalized Basic EPS	2.6	2.64	2.79	3.11	2.79
Normalized Diluted EPS	2.59	2.63	2.78	3.11	2.78
Dividend Per Share	2.1	2.16	2.18	2.36	2.4
Payout Ratio	74.14	72.2	73.73	-35.6	171.74
American Depositary Receipts Ratio (ADR)	0.2	0.2	0.2	0.2	0.2
Supplemental Items
EBITDA	12.16B	11.94B	12.18B	13.28B	11.82B
EBITA	11.41B	11B	11.65B	12.88B	11.45B
EBIT	11.07B	11B	11.65B	12.64B	9.8B
EBITDAR	-	11.95B	12.2B	13.29B	11.83B
Effective Tax Rate - (Ratio)	24.31	23.89	26.58	16.83	10.09
Current Domestic Taxes	38M	-25M	-3M	32M	103M
Current Foreign Taxes	2.39B	2.4B	2.72B	2.78B	2.68B
Total Current Taxes	2.42B	2.38B	2.72B	2.81B	2.78B
Total Deferred Taxes	-317M	-187M	-240M	-5.68B	-2.42B
Normalized Net Income	5.94B	6.05B	6.29B	6.94B	6.18B
Interest on Long-Term Debt	-	24M	25M	30M	38M
Non-Cash Pension Expense	-	-28M	-29M	-33M	-39M
Supplemental Operating Expense Items
Marketing Expenses	-	1.24B	1.16B	1.15B	1.11B
Selling and Marketing Expenses	-	1.24B	1.16B	1.15B	1.11B
Research And Development Expense From Footnotes	307M	304M	323M	408M	380M
Net Rental Expense, Total	-	9M	12M	14M	9M
Imputed Operating Lease Interest Expense	-	2.59M	3.85M	4.91M	3.32M
Imputed Operating Lease Depreciation	-	6.41M	8.15M	9.09M	5.68M
Stock-Based Comp., SG&A Exp. (Total)	-	78M	85M	-	74M
Total Stock-Based Compensation	-	78M	85M	-	74M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	3.14B	2.81B	3.45B	4.66B	5.3B
Short Term Investments	242M	-	-	-	-
Trading Asset Securities, Total	-	456M	579M	601M	513M
Total Cash And Short Term Investments	3.38B	3.26B	4.02B	5.26B	5.81B
Accounts Receivable, Total	3.72B	3B	2.61B	2.89B	2.86B
Other Receivables	79M	1.07B	1.91B	906M	816M
Total Receivables	3.8B	4.07B	4.52B	3.79B	3.67B
Inventory	6B	5.28B	5.67B	4.94B	4.62B
Other Current Assets, Total	433M	195M	1.2B	195M	197M
Total Current Assets	13.61B	12.81B	15.41B	14.19B	14.29B
Gross Property Plant And Equipment	-	8.97B	9.51B	9.04B	8.85B
Accumulated Depreciation	-	-4.02B	-4.64B	-4.46B	-4.47B
Net Property Plant And Equipment	5.06B	4.95B	4.87B	4.58B	4.38B
Long-term Investments	1.82B	2B	2.14B	2.09B	2.05B
Goodwill	-	43.19B	47.96B	41.09B	41.13B
Other Intangibles, Total	115B	72.43B	81.12B	54.47B	53.15B
Deferred Tax Assets Long-Term	534M	611M	682M	911M	2.57B
Other Long-Term Assets, Total	1.32B	1.37B	1.37B	1.39B	1.33B
Total Assets	138B	137B	154B	119B	119B
Liabilities
Accounts Payable, Total	9.69B	3.92B	4.06B	1.71B	1.71B
Accrued Expenses, Total	-	14M	14M	13M	11M
Short-term Borrowings	-	346M	106M	-	138M
Current Portion of Long-Term Debt	4.04B	3.52B	4.16B	4.19B	4.03B
Current Portion of Leases	-	126M	142M	131M	141M
Current Income Taxes Payable	868M	879M	1.05B	992M	1.68B
Other Current Liabilities	876M	6.34B	8.32B	8.64B	11.03B
Total Current Liabilities	15.48B	15.14B	17.85B	15.67B	18.74B
Long-Term Debt	39.45B	35.35B	38.35B	35.23B	32.19B
Long-Term Leases	475M	320M	375M	367M	444M
Pension & Other Post Retirement Benefits	1.52B	1.27B	979M	910M	851M
Deferred Tax Liability Non Current	16.31B	16.46B	18.43B	12.19B	11.68B
Other Non Current Liabilities	1.49B	1.43B	1.85B	1.41B	4.99B
Total Liabilities	74.74B	69.96B	77.84B	65.78B	68.9B
Preferred Stock - Others	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	614M	614M	614M	614M	585M
Additional Paid In Capital	26.62B	107M	113M	115M	121M
Retained Earnings	42.04B	49.33B	51.2B	31.63B	26.02B
Treasury Stock	-	-5.12B	-7.12B	-7.1B	-4.41B
Comprehensive Income and Other	-6.6B	22.17B	30.56B	27.31B	27.33B
Total Common Equity	62.67B	67.1B	75.37B	52.57B	49.64B
Minority Interest	282M	300M	342M	368M	352M
Total Equity	62.96B	67.4B	75.71B	52.93B	50B
Total Liabilities And Equity	138B	137B	154B	119B	119B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.29B	2.29B	2.23B	2.23B	2.2B
ECS Total Common Shares Outstanding	2.29B	2.29B	2.23B	2.23B	2.2B
Book Value / Share	27.42	28.59	33.04	22.81	21.77
Tangible Book Value	-52.67B	-48.52B	-53.71B	-43B	-44.63B
Tangible Book Value Per Share	-23.04	-21.94	-24.84	-20.03	-21.03
Total Debt	43.97B	39.66B	43.14B	39.92B	36.95B
Net Debt	40.59B	36.39B	39.11B	34.66B	31.14B
Debt Equivalent of Unfunded Proj. Benefit Obligation	794M	-230M	-574M	-525M	-554M
Debt Equivalent Oper. Leases	-	72M	96M	112M	72M
Minority Interest, Total (Incl. Fin. Div)	282M	300M	342M	368M	352M
Equity Method Investments, Total	1.8B	1.95B	2.02B	1.97B	1.9B
Account Code - Inventory Valuation	3	6	6	6	6
Inventories - Raw Materials, Total	-	2.1B	2.37B	2.2B	2.06B
Inventories - Finished Goods, Total	-	3.18B	3.3B	2.74B	2.56B
Land - (BS)	-	242M	246M	-	-
Machinery, Total	-	6B	6.32B	6.08B	6B
Full Time Employees	-	54.36K	52.08K	46.72K	48.99K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	-	37M	51M	70M	45M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	6.4B	6.8B	6.67B	-14.37B	3.07B
Depreciation & Amortization - CF	751M	938M	531M	492M	462M
Amortization of Goodwill and Intangible Assets - (CF)	339M	-	-	237M	1.65B
Depreciation & Amortization, Total	1.09B	938M	531M	729M	2.11B
Amortization of Deferred Charges, Total - (CF)	-	-	-	120M	120M
(Gain) Loss From Sale Of Asset	-	-	554M	-	-
Asset Writedown & Restructuring Costs	360M	138M	220M	27.76B	867M
(Income) Loss On Equity Investments - (CF)	-	-	-	-585M	-1.9B
Other Operating Activities, Total	1.83B	1.9B	2.32B	-2.48B	80M
Change In Accounts Receivable	300M	-393M	-42M	-487M	-269M
Change In Inventories	-144M	433M	-246M	265M	35M
Change In Accounts Payable	-320M	183M	3M	640M	58M
Change in Other Net Operating Assets	273M	-285M	388M	-887M	5.95B
Cash from Operations	9.79B	9.72B	10.39B	10.71B	10.12B
Capital Expenditure	-511M	-527M	-523M	-460M	-486M
Sale of Property, Plant, and Equipment	44M	31M	31M	54M	145M
Cash Acquisitions	-	-	-	-	-
Divestitures	-	-98M	-	159M	-
Sale (Purchase) of Intangible assets	-244M	-218M	-130M	-114M	-83M
Investment in Marketable and Equity Securities, Total	-120M	-361M	-168M	-80M	1.61B
Other Investing Activities, Total	48M	33M	85M	145M	187M
Cash from Investing	-783M	-1.14B	-705M	-296M	1.38B
Long-Term Debt Issued, Total	9.83B	978M	3.27B	5.13B	2.4B
Total Debt Issued	9.83B	978M	3.27B	5.13B	2.4B
Long-Term Debt Repaid, Total	-10.8B	-5B	-3.26B	-6.93B	-4.99B
Total Debt Repaid	-10.8B	-5B	-3.26B	-6.93B	-4.99B
Issuance of Common Stock	-	1.68B	-	-	-
Repurchase of Common Stock	-18M	-82M	-2.09B	-110M	-792M
Common Dividends Paid	-4.74B	-4.91B	-4.92B	-5.11B	-5.27B
Common & Preferred Stock Dividends Paid	-4.74B	-4.91B	-4.92B	-5.11B	-5.27B
Other Financing Activities, Total	-2.16B	-1.42B	-1.87B	-2.29B	-1.98B
Cash from Financing	-7.9B	-8.75B	-8.88B	-9.31B	-10.63B
Foreign Exchange Rate Adjustments	-253M	-253M	431M	-292M	-281M
Miscellaneous Cash Flow Adjustments	-	-	-368M	368M	-
Net Change in Cash	853M	-425M	874M	1.18B	587M
Supplemental Items
Cash Interest Paid	1.76B	1.5B	1.6B	1.71B	1.74B
Cash Income Tax Paid (Refund)	2.13B	2.31B	2.54B	2.62B	1.85B
Levered Free Cash Flow	6.69B	6.61B	6.65B	7.41B	10.28B
Unlevered Free Cash Flow	7.82B	7.55B	7.69B	8.56B	11.39B
Change In Net Working Capital	-570M	-404M	-446M	-381M	-3.52B
Net Debt Issued / Repaid	-971M	-4.02B	2M	-1.8B	-2.59B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	4.96	5	5.01	5.8	5.15
Return on Total Capital	6.39	6.43	6.45	7.45	6.81
Return On Equity %	10.33	10.7	9.57	-22.06	6.18
Return on Common Equity	10.11	10.47	9.29	-22.53	5.92
Margin Analysis
Gross Profit Margin %	83.95	82.1	82.63	82.07	82.33
SG&A Margin	10.29	14.83	13.85	14.13	15.27
EBITDA Margin %	47.17	46.48	44.05	48.66	45.7
EBITA Margin %	44.26	42.83	42.13	47.2	44.26
EBIT Margin %	42.94	42.83	42.13	46.33	37.87
Income From Continuing Operations Margin %	25.47	27.15	24.76	-52.01	12.3
Net Income Margin %	24.83	26.48	24.1	-52.66	11.86
Net Avail. For Common Margin %	24.83	26.43	23.93	-52.82	11.7
Normalized Net Income Margin	23.06	23.54	22.76	25.45	23.88
Levered Free Cash Flow Margin	25.96	25.74	24.06	27.17	39.73
Unlevered Free Cash Flow Margin	30.35	29.4	27.81	31.36	44.02
Asset Turnover
Asset Turnover	0.18	0.19	0.19	0.2	0.22
Fixed Assets Turnover	4.87	5.13	5.63	5.77	5.77
Receivables Turnover (Average Receivables)	6.6	8.92	9.86	9.93	9.01
Inventory Turnover (Average Inventory)	0.68	0.82	0.88	0.92	0.96
Short Term Liquidity
Current Ratio	0.88	0.85	0.86	0.91	0.76
Quick Ratio	0.46	0.48	0.48	0.58	0.51
Operating Cash Flow to Current Liabilities	0.63	0.64	0.58	0.68	0.54
Days Sales Outstanding (Average Receivables)	55.48	40.94	37	36.76	40.62
Days Outstanding Inventory (Average Inventory)	534.76	447.69	415.98	395.86	382.58
Average Days Payable Outstanding	879.23	359.78	280.21	156.65	147.16
Cash Conversion Cycle (Average Days)	-289	128.85	172.77	275.97	276.04
Long Term Solvency
Total Debt/Equity	69.84	58.84	56.98	75.41	73.91
Total Debt / Total Capital	41.12	37.04	36.3	42.99	42.5
LT Debt/Equity	63.42	52.92	51.15	67.24	65.28
Long-Term Debt / Total Capital	37.34	33.31	32.58	38.33	37.54
Total Liabilities / Total Assets	54.28	50.93	50.69	55.41	57.95
EBIT / Interest Expense	6.11	7.31	7.02	6.91	5.53
EBITDA / Interest Expense	6.71	7.94	7.34	7.31	6.72
(EBITDA - Capex) / Interest Expense	6.43	7.59	7.02	7.05	6.45
Total Debt / EBITDA	3.62	3.32	3.54	2.99	3.1
Net Debt / EBITDA	3.34	3.05	3.21	2.59	2.61
Total Debt / (EBITDA - Capex)	3.77	3.48	3.7	3.09	3.23
Net Debt / (EBITDA - Capex)	3.48	3.19	3.35	2.68	2.73
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-0.39	-0.36	7.67	-1.35	-5.19
Gross Profit, 1 Yr. Growth %	0.92	-1.13	8.37	-2.01	-4.89
EBITDA, 1 Yr. Growth %	6	-0.79	1.63	7.26	-10.23
EBITA, 1 Yr. Growth %	6.65	-0.43	6.33	7.67	-10.37
EBIT, 1 Yr. Growth %	8.35	-0.43	6.33	8.49	-21.85
Earnings From Cont. Operations, 1 Yr. Growth %	12.22	6.25	-1.84	-307.26	-122.42
Net Income, 1 Yr. Growth %	12.2	6.27	-1.99	-315.53	-121.35
Normalized Net Income, 1 Yr. Growth %	6.19	1.65	4.56	9.95	-10.2
Diluted EPS Before Extra, 1 Yr. Growth %	12.01	5.99	-1.25	-321.51	-121.03
Accounts Receivable, 1 Yr. Growth %	-9.09	8.51	-12.98	10.66	-1.11
Inventory, 1 Yr. Growth %	-1.58	-11.99	7.43	-12.93	-6.52
Net Property, Plant and Equip., 1 Yr. Growth %	-8.3	-2.11	-1.74	-5.84	-4.45
Total Assets, 1 Yr. Growth %	-2.35	-0.24	11.78	-22.68	0.15
Tangible Book Value, 1 Yr. Growth %	-4.04	-8.03	10.68	-19.94	3.81
Common Equity, 1 Yr. Growth %	-1.92	7.22	12.32	-30.25	-5.56
Cash From Operations, 1 Yr. Growth %	8.78	-0.71	6.97	3.08	-5.5
Capital Expenditures, 1 Yr. Growth %	-23.04	3.13	-0.76	-12.05	5.65
Levered Free Cash Flow, 1 Yr. Growth %	60.92	-0.81	-0.63	5.8	38.51
Unlevered Free Cash Flow, 1 Yr. Growth %	49.52	-3.16	0.99	6.64	32.94
Dividend Per Share, 1 Yr. Growth %	3.65	2.47	1.02	2	2
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	2.59	-0.37	3.58	3.07	-3.29
Gross Profit, 2 Yr. CAGR %	4.17	-0.77	3.51	3.05	-3.93
EBITDA, 2 Yr. CAGR %	5.95	2.3	0.62	6.03	-2.54
EBITA, 2 Yr. CAGR %	6.64	2.78	2.7	7.03	-1.58
EBIT, 2 Yr. CAGR %	5.04	2.78	2.7	7.65	-7.71
Earnings From Cont. Operations, 2 Yr. CAGR %	2.81	9.19	2.13	42.64	-31.83
Net Income, 2 Yr. CAGR %	3.01	9.19	2.06	45.34	-32.16
Normalized Net Income, 2 Yr. CAGR %	4.09	2.94	2.87	7.67	-0.37
Diluted EPS Before Extra, 2 Yr. CAGR %	2.94	8.96	2.3	47.9	-31.74
Accounts Receivable, 2 Yr. CAGR %	13.9	-5.67	-2.83	-1.87	4.61
Inventory, 2 Yr. CAGR %	-0.26	-6.93	-2.76	-3.28	-9.78
Net Property, Plant and Equip., 2 Yr. CAGR %	-1.03	-5.26	-1.93	-3.81	-5.15
Total Assets, 2 Yr. CAGR %	-3	-1.3	5.6	-7.04	-12
Tangible Book Value, 2 Yr. CAGR %	-5.24	-6.05	0.89	-5.87	-8.84
Common Equity, 2 Yr. CAGR %	-2.07	2.54	9.74	-11.49	-18.84
Cash From Operations, 2 Yr. CAGR %	-2.5	3.93	3.06	5	-1.3
Capital Expenditures, 2 Yr. CAGR %	-17.89	-10.91	1.17	-6.57	-3.6
Levered Free Cash Flow, 2 Yr. CAGR %	-7.98	27.02	-0.08	6.08	20.14
Unlevered Free Cash Flow, 2 Yr. CAGR %	-6.28	20.33	-0.67	6.77	18.28
Dividend Per Share, 2 Yr. CAGR %	3.82	3.06	1.74	4.52	5.03
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	9.63	1.6	2.24	1.91	0.24
Gross Profit, 3 Yr. CAGR %	14.19	1.96	2.19	1.63	0.33
EBITDA, 3 Yr. CAGR %	15.5	3.29	2.22	3.7	0.04
EBITA, 3 Yr. CAGR %	16.75	3.12	3.82	4.44	0.61
EBIT, 3 Yr. CAGR %	15.58	3.12	3.82	4.93	-3.52
Earnings From Cont. Operations, 3 Yr. CAGR %	-44.14	3.94	5.39	29.3	-23.02
Net Income, 3 Yr. CAGR %	-44.52	4.08	5.33	30.94	-23.31
Normalized Net Income, 3 Yr. CAGR %	-31.97	3.3	3.32	5.68	1.03
Diluted EPS Before Extra, 3 Yr. CAGR %	-46.56	3.95	5.44	32.35	-22.8
Accounts Receivable, 3 Yr. CAGR %	4.02	1.49	-8.17	1.47	-1.62
Inventory, 3 Yr. CAGR %	0.76	-4.33	-2.37	-6.28	-4.38
Net Property, Plant and Equip., 3 Yr. CAGR %	1.2	-1.39	-4.1	-3.25	-4.02
Total Assets, 3 Yr. CAGR %	-0.8	-2.09	2.88	-4.82	-4.7
Tangible Book Value, 3 Yr. CAGR %	-2.67	-6.13	-0.77	-6.59	-2.75
Common Equity, 3 Yr. CAGR %	1.09	0.88	5.7	-5.65	-9.56
Cash From Operations, 3 Yr. CAGR %	22.32	-1.91	4.93	3.07	1.38
Capital Expenditures, 3 Yr. CAGR %	-13.55	-11.41	-7.65	-3.44	-2.66
Levered Free Cash Flow, 3 Yr. CAGR %	13.98	-5.71	17.55	3.81	15.99
Unlevered Free Cash Flow, 3 Yr. CAGR %	14.54	-5.36	13.84	3.38	14.9
Dividend Per Share, 3 Yr. CAGR %	28.1	3.37	2.37	3.83	3.67
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	15.51	12.69	7.17	2.18	-0.01
Gross Profit, 5 Yr. CAGR %	17.89	15.19	9.48	2.39	-0.11
EBITDA, 5 Yr. CAGR %	17.91	15.73	9.07	4.15	0.72
EBITA, 5 Yr. CAGR %	17.94	15.27	10.2	5.12	1.91
EBIT, 5 Yr. CAGR %	17.54	15.92	10.2	4.73	-1.21
Earnings From Cont. Operations, 5 Yr. CAGR %	7.74	7.58	-28.89	17.97	-11.47
Net Income, 5 Yr. CAGR %	8.33	7.91	-29.21	18.95	-11.66
Normalized Net Income, 5 Yr. CAGR %	12.14	7.73	-19.72	4.83	1.59
Diluted EPS Before Extra, 5 Yr. CAGR %	3.9	3.47	-30.71	19.69	-11.39
Accounts Receivable, 5 Yr. CAGR %	9.58	2.15	-4.63	0.13	-3.26
Inventory, 5 Yr. CAGR %	7.15	-1.84	-0.67	-3.91	-5.4
Net Property, Plant and Equip., 5 Yr. CAGR %	10.87	6.23	-0.06	-2.37	-4.52
Total Assets, 5 Yr. CAGR %	34.3	28.13	1.71	-4.1	-3.35
Tangible Book Value, 5 Yr. CAGR %	56.38	64.53	-1.22	-6.02	-4.08
Common Equity, 5 Yr. CAGR %	67.15	52.66	4.43	-4.26	-4.9
Cash From Operations, 5 Yr. CAGR %	15.7	16.08	14.22	0.8	2.39
Capital Expenditures, 5 Yr. CAGR %	1.13	-2.1	-7.94	-9.51	-6.05
Levered Free Cash Flow, 5 Yr. CAGR %	22.57	20.13	8.05	-1.23	20.2
Unlevered Free Cash Flow, 5 Yr. CAGR %	23.02	19.91	8.12	-0.8	16.91
Dividend Per Share, 5 Yr. CAGR %	6.44	4.94	16.82	3.83	3.43